{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:32:42Z","timestamp":1771947162519,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.pbb.2007.02.012","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:16:34Z","timestamp":1172060194000},"page":"667-677","source":"Crossref","is-referenced-by-count":9,"title":["Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers"],"prefix":"10.1016","volume":"86","author":[{"given":"Nathalie V.","family":"Goletiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack H.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle B.","family":"Sholar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Skupny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy K.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2007.02.012_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/jc.75.2.552","article-title":"Effects of loperamide on the human hypothalamo\u2013pituitary\u2013adrenal axis in vivo and in vitro","volume":"75","author":"Auernhammer","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1159\/000126466","article-title":"Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro","volume":"57","author":"Auernhammer","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000126715","article-title":"In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide","volume":"60","author":"Auernhammer","year":"1994","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/jpet.103.050682","article-title":"Suppressed prolactin response to dynorphin A1\u201313 in methadone-maintained versus control subjects","volume":"306","author":"Bart","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib5","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(91)90799-2","article-title":"Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists","volume":"567","author":"Baumann","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2007.02.012_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/edrv-6-4-564","article-title":"Dopamine: a prolactin-inhibiting hormone","volume":"6","author":"Ben-Jonathan","year":"1985","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pbb.2007.02.012_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/er.22.6.724","article-title":"Dopamine as a prolactin (PRL) inhibitor","volume":"22","author":"Ben-Jonathan","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pbb.2007.02.012_bib9","first-page":"66","article-title":"Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine","volume":"55","author":"Bigelow","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pbb.2007.02.012_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0306-4530(01)00053-1","article-title":"The effects of heroin on prolactin levels in male rhesus monkeys: use of cumulative-dosing procedures","volume":"27","author":"Bowen","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.npp.1300105","article-title":"Effects of mixed-action kappa\u2013mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys","volume":"28","author":"Bowen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000123927","article-title":"Differences in hypothalamo\u2013pituitary\u2013adrenocortical activity in the rat after acute and prolonged treatment with morphine","volume":"38","author":"Buckingham","year":"1984","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000124481","article-title":"Effects of naloxone on hypothalamo\u2013pituitary\u2013adrenocortical activity in the rat","volume":"42","author":"Buckingham","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(01)01121-9","article-title":"Kappa-opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D(2)-like receptor agonists","volume":"423","author":"Butelman","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-2999(99)00640-8","article-title":"Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys","volume":"383","author":"Butelman","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002130051144","article-title":"Effects of E-2078, a stable dynorphin A(1\u20138) analog, on sedation and serum prolactin levels in rhesus monkeys","volume":"147","author":"Butelman","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.02.012_bib17","first-page":"678","article-title":"Effects of systemically administered dynorphin A(1\u201317) in rhesus monkeys","volume":"290","author":"Butelman","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(24)29474-X","article-title":"GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys","volume":"298","author":"Butelman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-002-1195-y","article-title":"Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys","volume":"164","author":"Butelman","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.02.012_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4530(03)00030-1","article-title":"Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys","volume":"29","author":"Butelman","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(89)90109-1","article-title":"Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro","volume":"505","author":"Colagero","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2007.02.012_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0143-4179(95)90025-X","article-title":"Opioid peptide inhibition of endogenous norepinephrine release from the A2 noradrenergic cell group in vitro","volume":"28","author":"Carr","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2007.02.012_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1213\/00000539-199211000-00016","article-title":"Nalbuphine is better than naloxone for treatment of side effects after epidural morphine","volume":"75","author":"Cohen","year":"1992","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pbb.2007.02.012_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2826.1996.tb00691.x","article-title":"The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic\u2013pituitary\u2013adrenal axis: studies in vivo and in vitro","volume":"8","author":"Colagero","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1677\/joe.0.1690185","article-title":"Endomorphins and activation of the hypothalamo\u2013pituitary\u2013adrenal axis","volume":"169","author":"Coventry","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pbb.2007.02.012_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-57-6-1179","article-title":"Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man","volume":"57","author":"Degli Uberti","year":"1983","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2265.1983.tb00017.x","article-title":"The participation of hypothalamic dopamine in morphine-induced prolactin release in man","volume":"19","author":"Delitala","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pbb.2007.02.012_bib28","first-page":"193","article-title":"Kappa agonist-induced reduction in dopamine release: site of action and tolerance","volume":"78","author":"Donzanti","year":"1992","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0091-3057(80)90431-1","article-title":"Effects of heroin and naltrexone on plasma prolactin levels in man","volume":"12","author":"Ellingboe","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2007.02.012_bib30","first-page":"1121","article-title":"Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor","volume":"278","author":"Emmerson","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-198326030-00002","article-title":"Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy","volume":"26","author":"Errick","year":"1983","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2007.02.012_bib32","first-page":"623","article-title":"The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans","volume":"261","author":"Foltin","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib33","first-page":"38","article-title":"Effects of single and multiple intravenous cocaine injections in humans maintained on methadone","volume":"275","author":"Foltin","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.1986.tb03611.x","article-title":"Evidence for serotoninergic system involvement in opioid control of luteinizing hormone secretion in man","volume":"25","author":"Foresta","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pbb.2007.02.012_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-3-1","article-title":"Activity of opioid ligands in cells expressing cloned mu opioid receptors","volume":"3","author":"Gharagozlou","year":"2003","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(82)90579-9","article-title":"Increase of plasma corticosterone induced by loperamide in rats","volume":"79","author":"Giagnoni","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/jcem-60-2-299","article-title":"Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey","volume":"60","author":"Gilbeau","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0300-595X(83)80062-0","article-title":"Brain opiates and neuroendocrine function","volume":"12","author":"Grossman","year":"1983","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0006-3223(01)01334-8","article-title":"Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism","volume":"51","author":"Hernandez-Avila","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.02.012_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4530(88)90046-7","article-title":"Human studies on the mu opiate receptor agonist fentanyl: neuroendocrine and behavioral responses","volume":"13","author":"Hoehe","year":"1988","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2826.2001.00713.x","article-title":"Paradoxical effects of chronic morphine treatment on the temperature and pituitary\u2013adrenal responses to acute restraint stress: a chronic stress paradigm","volume":"13","author":"Houshyar","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2826.2001.00714.x","article-title":"Differential responsivity of the hypothalamic\u2013pituitary\u2013adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses","volume":"13","author":"Houshyar","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib43","series-title":"The pharmacological basis of therapeutics","first-page":"485","article-title":"Opioid analgesics and antagonists","author":"Jaffe","year":"1990"},{"key":"10.1016\/j.pbb.2007.02.012_bib44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.eurheartj.a062328","article-title":"Nalbuphine versus diamorphine early in the course of suspected myocardial infarction","volume":"8","author":"Jamidar","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pbb.2007.02.012_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1011027717543","article-title":"Role of cholinergic and GABAergic neurotransmission in the opioids-mediated GnRH release mechanism of EBP-primed OVX rats","volume":"219","author":"Kaur","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pbb.2007.02.012_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2044.1985.tb10746.x","article-title":"Influence of meptazinol on metabolic and hormonal responses following major surgery. A comparison with morphine","volume":"40","author":"Kay","year":"1985","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pbb.2007.02.012_bib47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0893-133X(01)00416-X","article-title":"Hypothalamic\u2013pituitary\u2013adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism","volume":"26","author":"King","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib48","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/0024-3205(84)90676-3","article-title":"Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat","volume":"34","author":"Koenig","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2007.02.012_bib49","series-title":"Recent developments in chemotherapy of narcotic addiction","first-page":"110","article-title":"Medical complications in methadone patients","author":"Kreek","year":"1978"},{"key":"10.1016\/j.pbb.2007.02.012_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(24)37950-9","article-title":"Dynorphin A1\u201313 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions","volume":"288","author":"Kreek","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-6576.1984.tb02066.x","article-title":"Cardiorespiratory effects of nalbuphine and morphine premedication in adult cardiac surgical patients","volume":"28","author":"Lake","year":"1984","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.pbb.2007.02.012_bib52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0022-4731(87)90138-5","article-title":"Gonadal steroid modulation of brain opioid systems","volume":"27","author":"Limonta","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.pbb.2007.02.012_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0361-9230(89)90024-5","article-title":"Opioid inhibition of spontaneously active neurons of the rat arcuate nucleus in vitro","volume":"22","author":"Loose","year":"1989","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2007.02.012_bib54","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1523\/JNEUROSCI.10-11-03627.1990","article-title":"Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus","volume":"10","author":"Loose","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2007.02.012_bib56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0024-3205(93)90501-S","article-title":"Kappa opioid receptor-mediated regulation of prolactin and alpha-melanocyte-stimulating hormone secretion in male and female rats","volume":"53","author":"Manzanares","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2007.02.012_bib57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0736-5748(98)00030-6","article-title":"Anterior pituitary response to stress: time-related changes and adaptation","volume":"16","author":"Marti","year":"1998","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.pbb.2007.02.012_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/joe.0.1280281","article-title":"Analysis of the receptor specificity of tolerance induction in stress versus opioid-related prolactin secretion in rats","volume":"128","author":"Matton","year":"1991","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pbb.2007.02.012_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bjsm.30.1.69","article-title":"Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use","volume":"30","author":"McBride","year":"1996","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.pbb.2007.02.012_bib61","series-title":"The archer conference on drug abuse: new medications","first-page":"104","article-title":"Interactions between kappa opioid agonists and cocaine: preclinical studies","author":"Mello","year":"2000"},{"key":"10.1016\/j.pbb.2007.02.012_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/npp.1993.6","article-title":"The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkey","volume":"8","author":"Mello","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib63","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.npp.1300631","article-title":"Effects of the mixed mu\/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men","volume":"30","author":"Mello","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0091-3057(86)90356-4","article-title":"Use of naltrexone as a provocative test for hypothalamic\u2013pituitary hormone function","volume":"24","author":"Mendelson","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2007.02.012_bib65","series-title":"Problems of drug dependence 1990","first-page":"161","article-title":"Use of naltrexone for the diagnosis and treatment of reproductive hormone disorders in women","author":"Mendelson","year":"1991"},{"key":"10.1016\/j.pbb.2007.02.012_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0306-4530(01)00036-1","article-title":"Temporal concordance of cocaine effects on mood states and neuroendocrine hormones","volume":"27","author":"Mendelson","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1124\/jpet.103.052928","article-title":"Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone and prolactin in men","volume":"307","author":"Mendelson","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib68","first-page":"942","article-title":"Evaluation of nalbuphine hydrochloride","volume":"37","author":"Miller","year":"1980","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.pbb.2007.02.012_bib69","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/endo-125-4-1863","article-title":"Fentanyl stimulates prolactin release through mu-opiate receptors, but not the serotonergic system","volume":"125","author":"Pan","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0306-3623(93)90017-R","article-title":"Central effects of naloxone and selected opioid agonists on cortisol and prolactin secretion in non-stressed sheep","volume":"24","author":"Parrott","year":"1993","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib71","series-title":"Physicians desk reference","year":"2003"},{"key":"10.1016\/j.pbb.2007.02.012_bib72","series-title":"Physicians desk reference","author":"PDR","year":"2005"},{"key":"10.1016\/j.pbb.2007.02.012_bib73","first-page":"178","article-title":"Evaluation of the effects induced by four opiate drugs with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men","volume":"40","author":"Pende","year":"1986","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pbb.2007.02.012_bib74","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1210\/endo-116-6-2688","article-title":"Central kappa- and mu-opiate receptors mediate ACTH-release in rats","volume":"116","author":"Pfeiffer","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-2007-1012453","article-title":"Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man","volume":"18","author":"Pfeiffer","year":"1986","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pbb.2007.02.012_bib76","first-page":"1044","article-title":"Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice","volume":"262","author":"Pick","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib77","first-page":"114","article-title":"Effects of agonist\u2013antagonist opioids in humans trained in a hydromorphone\/not hydromorphone discrimination","volume":"295","author":"Preston","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(91)90053-2","article-title":"Abuse liability studies of opioid agonist\u2013antagonists in humans","volume":"28","author":"Preston","year":"1991","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2007.02.012_bib79","first-page":"929","article-title":"Antagonist effects of nalbuphine in opioid-dependent human volunteers","volume":"248","author":"Preston","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/acta.0.1040257","article-title":"Changes in pituitary secretion induced by an agonist\u2013antagonist opioid drug, buprenorphine","volume":"104","author":"Rolandi","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.pbb.2007.02.012_bib81","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/clpt.1980.67","article-title":"Ceiling effect for respiratory depression by nalbuphine","volume":"27","author":"Romagnoli","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2125.1988.tb03367.x","article-title":"Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects","volume":"26","author":"Saarialho-Kere","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0773.1989.tb01168.x","article-title":"Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers","volume":"65","author":"Saarialho-Kere","year":"1989","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2007.02.012_bib84","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1530-0277.1998.tb03931.x","article-title":"Nalmefene causes greater hypothalamic\u2013pituitary\u2013adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism","volume":"22","author":"Schluger","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2007.02.012_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1600-0447.106.s412.26.x","article-title":"The effects of drug abuse on the stress responsive hypothalamic\u2013pituitary\u2013adrenal axis and the dopaminergic and endogenous opioid systems","author":"Schlussman","year":"2002","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.pbb.2007.02.012_bib86","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1139\/y88-226","article-title":"Morphine can stimulate prolactin release independent of a dopaminergic mechanism","volume":"66","author":"Shin","year":"1988","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib87","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000125918","article-title":"Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist","volume":"54","author":"Simpkins","year":"1991","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib88","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.6285470","article-title":"Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms","volume":"217","author":"Spiegel","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pbb.2007.02.012_bib89","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1507\/endocrj1954.33.441","article-title":"Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary\u2013adrenocortical activity","volume":"33","author":"Suemaru","year":"1986","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.pbb.2007.02.012_bib90","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jcem-66-6-1181","article-title":"Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal and gonadal hormones during the early follicular phase of the menstrual cycle","volume":"66","author":"Teoh","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib91","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","article-title":"Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","volume":"20","author":"Thompson","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2007.02.012_bib92","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0700971","article-title":"The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man","volume":"120","author":"Ur","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2007.02.012_bib93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130100723","article-title":"Subjective psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers","volume":"155","author":"Walker","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2007.02.012_bib94","first-page":"524","article-title":"Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","volume":"279","author":"Walsh","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of \u03ba-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib96","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1530-0277.1999.tb04276.x","article-title":"Adrenocortical responses and family history of alcoholism","volume":"23","author":"Wand","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2007.02.012_bib97","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jc.84.1.64","article-title":"Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men","volume":"84","author":"Wand","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pbb.2007.02.012_bib98","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0306-4530(02)00037-9","article-title":"Effect of opioid receptor antagonists on hypothalamic\u2013pituitary\u2013adrenal activity in rhesus monkeys","volume":"28","author":"Williams","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2007.02.012_bib99","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/105504999305965","article-title":"Nalbuphine hydrochloride dependence in anabolic steroid users","volume":"8","author":"Wines","year":"1999","journal-title":"Am J Addict"},{"key":"10.1016\/j.pbb.2007.02.012_bib100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/emj.19.6.565","article-title":"Hitting them where it hurts? Low dose nalbuphine therapy","volume":"19","author":"Woollard","year":"2002","journal-title":"Emerg Med J"},{"key":"10.1016\/j.pbb.2007.02.012_bib101","series-title":"Reproductive endocrinology: physiology, pathophysiology, and clinical management","first-page":"257","article-title":"Prolactin in human reproduction","author":"Yen","year":"1999"},{"key":"10.1016\/j.pbb.2007.02.012_bib102","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0022-3565(24)36921-6","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers","volume":"282","author":"Zacny","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.02.012_bib103","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00213-003-1716-3","article-title":"Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"173","author":"Zhang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.02.012_bib104","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.02.012_bib105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.0.1630261","article-title":"Hypothalamic\u2013pituitary\u2013adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress","volume":"163","author":"Zhou","year":"1999","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pbb.2007.02.012_bib106","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:58:33Z","timestamp":1736812713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305707000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0091305707000834"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2007.02.012","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}